Fecal bile acids and neutral sterols in patients with familial polyposis
Open Access
- 1 October 1976
- Vol. 38 (4) , 1694-1698
- https://doi.org/10.1002/1097-0142(197610)38:4<1694::aid-cncr2820380442>3.0.co;2-m
Abstract
Fecal neutral steroids and bile acids were measured in patients with familial polyposis, family controls who are immediate relatives of patients, and controls other than relatives. All subjects were consuming a mixed Western diet at the time of collection of stool specimens. Although the total fecal neutral sterol concentrations were not different between the groups, the patients with familial polyposis excreted a high amount of cholesterol and low levels of coprostanol and coprostanone compared with other groups. Patients with familial polyposis excreted levels of total bile acids in their feces comparable to those excreted by controls; lithocholic acid excretion was decreased in patients with familial polyposis. These findings suggest that analysis of stools for cholesterol and its metabolites be useful in screening the siblings of polyposis families for latent disease.This publication has 16 references indexed in Scilit:
- GUT BACTERIA AND THEIR METABOLIC ACTIVITIES IN FAMILIAL POLYPOSISThe Lancet, 1975
- FÆCAL BILE-ACIDS AND CLOSTRIDIA IN PATIENTS WITH CANCER OF THE LARGE BOWELThe Lancet, 1975
- Proliferative patterns in colonic mucosa in familial polyposisCancer, 1975
- Phase 1 and phase 2 proliferative lesions of colonic epithelial cells in diseases leading to colonic cancerCancer, 1974
- The Different Effects on the Serum Lipids and Fecal Steroids of High Carbohydrate Diets Given Orally or IntravenouslyJournal of Clinical Investigation, 1973
- Polyps of the colon and rectum in cali, ColombiaInternational Journal of Cancer, 1972
- Polyps and carcinoma of the large bowel in the South African BantuCancer, 1970
- Familial multiple polyposis.A statistical study of a large kentucky kindredCancer, 1970
- Genetic Factors in Intestinal PolyposisJAMA, 1962
- THE BLOOD FACTOR C OF THE A-B-O SYSTEM, WITH SPECIAL REFERENCE TO THE RARE BLOOD GROUP CAnnals of Eugenics, 1952